Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics in the United States, April 2014

You might be interested in: biotech, biomedical, protein, more »

» Purchase Premium Reports

1-30 of about 800 reports
Commercial Potential of the Forthcoming US Biosimilars Market 

Commercial Potential of the Forthcoming US Biosimilars Market 

  • $ 5 000
  • Industry report
  • February 2014
  • by Frost & Sullivan

An Addendum to “Specialty Physicians Discuss their Opinions of the United States Biosimilars Market” Executive Summary •The arrival of biosimilars, or highly similar copies of biopharmaceutical products, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

  • $ 4 650
  • Industry report
  • March 2014
  • by MarketsandMarkets

Alcohol enzymes are extensively used in various industrial applications that incorporate the production of food and beverages, biofuels, cleaning agents, and others. Due to their versatile applications, ...

  • Industries : Biopharmaceutical
  • Countries : World, France, United States, South Africa, North America, Brazil, Mexico, Canada, Germany, Japan, India, China, Europe, Africa
Food Formulation Trends: Ingredients Consumers Avoid

Food Formulation Trends: Ingredients Consumers Avoid

  • $ 3 750
  • Industry report
  • February 2014
  • by Packaged Facts

Food avoidance has become a way of life for tens of millions of American consumers of all ages. For consumers with allergies and intolerances, avoiding certain food and ingredients is a matter of life ...

  • Industries : Diet Food, Genetically Modified Organism, Gmo
  • Countries : United States
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

  • $ 3 063
  • Industry report
  • May 2014
  • by Kelly Scientific Publications

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 280 tables & figures ...

  • Industries : Genomics
  • Countries : World, United States
Biomarker Partnering Terms and Agreements

Biomarker Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • April 2014
  • by Currentpartnering

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Genomics
  • Countries : United States
United States Orthobiologics Market Outlook to 2020

United States Orthobiologics Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

United States Orthobiologics Market Outlook to 2020 Summary GlobalData's new report, "United States Orthobiologics Market Outlook to 2020", provides key market data on the United States Orthobiologics ...

  • Industries : Biomaterial, Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014', provides an overview of the Retinitis Pigmentosa ...

  • Industries : Biological Therapy
  • Countries : United States, World
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414

  • $ 1 995
  • Industry report
  • February 2014
  • by Plunkett Research

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414 Vital industry-specific ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Personalized Cancer Genome Sequencing Market Outlook 2018

US Personalized Cancer Genome Sequencing Market Outlook 2018

  • $ 1 200
  • Industry report
  • March 2014
  • by RNCOS

The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate. There has been a rapid progression from targeted gene sequencing to targeted whole genome sequencing ...

  • Industries : Genomics
  • Countries : United States
Global Antibody Drug Conjugate Market Outlook 2018

Global Antibody Drug Conjugate Market Outlook 2018

  • $ 1 200
  • Industry report
  • March 2014
  • by RNCOS

The ADC technology is not new. It dates back to the 90s. However, several issues such as specificity of the payload (drug), and poor conjugation of drug and antibody proved a setback. But, the past few ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • March 2014
  • by La Merie Publishing

Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics Partnering 2009-2014

Seattle Genetics Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Partnering Agreements ...

  • Industries : Genomics
  • Countries : United States
Physician Views - Are physicians getting the biosimilar education they need?

Physician Views - Are physicians getting the biosimilar education they need?

  • $ 731
  • Industry report
  • April 2014
  • by Firstword Pharma

Biosimilars remain one of the pharmaceutical industry's hot topics. Branded biologics account for 7 of the 10 best selling drugs globally and significant legislative momentum was provided in 2013 when ...

  • Industries : Biopharmaceutical
  • Countries : United States
Freedonia Focus on Enzymes: United States

Freedonia Focus on Enzymes: United States

  • $ 600
  • Industry report
  • January 2014
  • by Freedonia Focus

This report forecasts US enzyme demand in US dollars at the manufacturers' level to 2017. Total demand is segmented by product in terms of carbohydrases, proteases, polymerases and nucleases, and othe ...

  • Industries : Biopharmaceutical
  • Countries : United States
North America Orthobiologics Procedures Outlook to 2020

North America Orthobiologics Procedures Outlook to 2020

  • $ 450
  • Industry report
  • March 2014
  • by Global Data

North America Orthobiologics Procedures Outlook to 2020 Summary GlobalData's new report, "North America Orthobiologics Procedures Outlook to 2020", provides key procedures data on the North America Orthobiologics ...

  • Industries : Biomaterial, Blood Supply, Tissue Banking and Transplantation
  • Countries : North America, United States, Mexico, Canada, World
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors

Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors

  • $ 396
  • Industry report
  • February 2014
  • by La Merie Publishing

CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors provides a ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • April 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
  • Countries : United States
Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
American Oriental Bioengineering, Inc. (AOBI) - Financial and Strategic SWOT Analysis Review

American Oriental Bioengineering, Inc. (AOBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

Summary This comprehensive SWOT profile of American Oriental Bioengineering, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
  • Countries : United States
Tiens Biotech Group (Symbol:USA) SWOT Analysis, Strategy, Revenues and Profits

Tiens Biotech Group (Symbol:USA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company. The company operates in research and development of products to prevent and disperse biofilms in medical and industrial applications. ...

  • Industries : Biotechnology
  • Countries : Canada, United States
American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Eurofins Scientific SE (Symbol:ERF) SWOT Analysis, Strategy, Revenues and Profits

Eurofins Scientific SE (Symbol:ERF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States, World, Luxembourg
Royalty Pharma SWOT Analysis, Strategy, Revenues and Profits

Royalty Pharma SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States, Ireland
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

Summary AdvanSource Biomaterials Corporation (AdvanSource) is a biomaterial manufacturing company. The company develops polymer based materials for the medical and pharmaceutical industries. Its products ...

  • Industries : Biomaterial
  • Countries : United States
American Vietnamese Biotech Inc (Symbol:AMV) SWOT Analysis, Strategy, Revenues and Profits

American Vietnamese Biotech Inc (Symbol:AMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States, Vietnam

» Read our Company Profiles

22 Companies

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.